NGNE - Neurogene Inc. PEG multiplikatori
Neurogene Inc. barqaror AQSh huquqiy bazasiga va tibbiyotning gumanitar maqomiga tayanadi. GURU.Markets platformasida o'sishga normallashtirilgan P/E ko'rsatkichi aniq ko'rsatilgan bo'lib, u yerda 0.00 parametrning joriy holatini aks ettiradi. Global sanksiyalar biomateriallar logistikasini murakkablashtirayotganiga qaramay, kompaniya rahbariyati intellektual mulkni samarali himoya qilmoqda va gen terapiyasi klinik sinovlarini o'tkazishda shaffoflikni saqlamoqda.
Neurogene Inc. (NGNE) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Neurogene Inc.|NGNE - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati neurogene.com|NGNE - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Neurogene Corp|NGNE - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Neurogene|Oraliq qoplash koeffitsiyenti neurogene.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
NGNE - Sof foyda|Kompaniya foydasi prognozi Neurogene Inc.|NGNE - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Neurogene Therapeutics|NGNE - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Neurogene Corp|NGNE - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Neurogene|NGNE - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi neurogene.com|NGNE - Joriy yilda foyda o'sishi|Keyingi yil uchun bitta aksiya uchun sof foyda o'sishi prognozi Neurogene Inc.
Kompaniyaning fundamental tahlili:Neurogene Inc (NGNE)
PEG koeffitsiyenti aktivning kengayishiga nisbatan qanchalik past baholanganlik darajasini aniqlash uchun P/E koeffitsiyentini kutilayotgan foyda o'sishi bilan solishtiradi. P/E baholash koeffitsiyenti va o'sish sur'atlari o'rtasidagi korrelyatsiyani tahlil qilish orqali investor Neurogene Inc. (NGNE) kompaniyasining salohiyatini baholaydi, bunda aksiya narxi kamyob kasalliklar gen terapiyasi bozoridagi kelajakdagi monopoliyani va intellektual mulkning uzoq muddatli himoyasini aks ettirishi kerak.
Raqobatdosh kompaniyalar
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Regencell Corp RGC|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACAD (acadia-pharm.com)|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - PEG multiplikatori|CPRX - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori DNLI|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|AMLX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Trevi Pharma - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Praxis Corp|AVXL (Anavex Life Sciences) - Narx-foyda va o‘sish multiplikatori|ceribell.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PRTA (Prothena Corporation plc) - PEG multiplikatori|Alector Therapeutics (ALEC) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|omeros.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ACIU (AC Immune)|VYGR - Narx-foyda va o‘sish multiplikatori|NMRA: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Scilex Holding SCLX|Tevogen Bio Holdings, Inc. (TVGN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ACOG|CGTX (Cognition Therapeutics) - PEG multiplikatori|IKT - Narxning sof foyda o‘sishiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cassava Sciences (SAVA)|assertiotx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. (VTGN) - O‘sish sur’atiga tuzatilgan narx-foyda|OVID - Narxning foydaga va o‘sish sur’atiga nisbati|ABOS (acumenpharm.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|CRVO: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Alterity Therapeutics Limited (ATHE)|Narx-foyda va o‘sish multiplikatori CLNN|PEG multiplikatori PepGen Corp|Narxning foydaga va o‘sish sur’atiga nisbati Jupiter Neurosciences Inc (JUNS)|RLMD (relmada.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Annovis Bio ANVS|Grace Therapeutics Inc (GRCE) - O‘sish sur’atiga tuzatilgan narx-foyda|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|KLTO (Klotho Neurosciences Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NRSN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revivapharma.com (RVPH)|Narx-foyda va o‘sish multiplikatori MTVA|PEG multiplikatori NeurAxis Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|PASG (passagebio.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|Athira Pharma - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Addex Therapeutics Ltd. (ADXN)|ALZN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Cyclerion Therapeutics, Inc. (CYCN)|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti KTTA (Pasithea)|PEG multiplikatori CRGT|ATXI - O‘sish sur’atiga tuzatilgan narx-foyda|Brainstorm Cell Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CARA|Chromocell Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Eliem Therapeutics ELYM|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti LBPH|MRNS (Marinus) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori NKGen Biotech Corp (NKGN)|Narx-foyda va o‘sish multiplikatori NRBO (NeuroBo Pharmaceuticals)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati sagerx.com|Narxning foydaga va o‘sish sur’atiga nisbati Synaptogenix SNPX|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Vigil Neuro - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Anew Medical Inc. (WENA)|Cerevel Therapeutics (CERE) - Narxning foydaga va o‘sish sur’atiga nisbati
